SOD2 and polycystic ovary syndrome: Compared with normal ovaries, the expression of SOD2 was stronger in the homogenates of polycystic ovaries with cancer at the early stage (PCOC-ES) and the late stage (PCOC-LS) (Figure 8(b)).